Assenagon Asset Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-32,657
Closed -$777K 1469
2024
Q2
$777K Hold
32,657
﹤0.01% 1157
2024
Q1
$974K Hold
32,657
﹤0.01% 1062
2023
Q4
$1.04M Hold
32,657
﹤0.01% 1084
2023
Q3
$955K Buy
32,657
+18,638
+133% +$670K ﹤0.01% 1052
2023
Q2
$631K Sell
14,019
-26,499
-65% -$1.01M ﹤0.01% 1080
2023
Q1
$1.4M Buy
40,518
+9,904
+32% +$322K 0.01% 952
2022
Q4
$853K Buy
+30,614
New +$811K ﹤0.01% 1080
2020
Q4
Sell
-19,671
Closed -$431K 1232
2020
Q3
$431K Buy
+19,671
New +$350K ﹤0.01% 986
2020
Q2
Sell
-195,992
Closed -$1.28M 1218
2020
Q1
$1.28M Buy
+195,992
New +$2.79M 0.01% 462

Other funds holding SGRY

Assenagon Asset Management's SGRY Position: Q3 2024 in Review

Assenagon Asset Management sold out of Surgery Partners (SGRY) in Q3 2024, closing a stake of 32,657 shares — an estimated $777K sold.

Assenagon Asset Management first reported a position in SGRY in Q1 2020 and held it in 9 quarters. The position peaked at $1.4M in Q1 2023. 183 funds tracked by Wall St. Rank hold SGRY as of Q3 2024.

  • Assenagon Asset Management reported no remaining Surgery Partners position as of Q3 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 32,657 Surgery Partners shares in Q3 2024, an estimated $777K.
  • Assenagon Asset Management first reported a position in Surgery Partners in Q1 2020 and held it in 9 quarters.
  • Assenagon Asset Management's Surgery Partners position peaked at $1.4M in Q1 2023.
  • 183 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2024.

Based on Assenagon Asset Management's 13F filing for Q3 2024, filed 23 Oct 2024.